Practice guidelines Non-invasive diagnosis and follow-up of primary biliary cholangitis

被引:4
|
作者
Corpechot, Christophe [1 ,2 ]
Heurgue, Alexandra [3 ]
Tanne, Florence [6 ]
Potier, Pascal [7 ]
Hanslik, Bertrand [8 ]
Decraecker, Marie [4 ,5 ]
de Ledinghen, Victor [4 ,5 ]
Ganne-Carrie, Nathalie [9 ,10 ]
Bureau, Christophe [11 ]
Bourliere, Marc [12 ,13 ]
机构
[1] Hop St Antoine, AP HP, Serv Hepatogastroenterol, 184 Rue Faubourg St Antoine, F-75012 Paris, France
[2] Univ Paris Sorbonne, Reference Ctr Inflammatory Biliary Dis & Autoimmu, French Network Rare Liver Dis Children & Adults F, European Reference Network Rare Hepatol Dis ERN R, Paris, France
[3] CHU Reims, Serv Hepatogastroenterol & Cancerol Digest, Reims, France
[4] CHU Bordeaux, Hop Haut Leveque, Serv Hepatogastroenterol, Pessac, France
[5] Univ Bordeaux, INSERM U1053, Bordeaux, France
[6] CHRU Brest Cavale Blanche, Serv Hepatogastroenterol, Brest, France
[7] CHR Orleans, Serv Hepatogastroenterol & Oncol Digest, Orleans, France
[8] Ctr Montpellierain Malad Foie & Appareil Digestif, Montpellier, France
[9] Univ Sorbonne Paris Nord, Hop Avicenne, AP HP, Serv Hepatol, Bobigny, France
[10] Univ Paris, Ctr Rech Cordeliers, INSERM UMR 1138, Paris, France
[11] CHU Toulouse, Serv Hepatol, Hop Rangueil, Toulouse, France
[12] Aix Marseille Univ, Serv Hepatogastroenterol, Hop St Joseph, Marseille, France
[13] Aix Marseille Univ, INSERM UMR 1252 IRD SESSTIM, Marseille, France
关键词
PBC; ACID-TREATED PATIENTS; URSODEOXYCHOLIC ACID; BIOCHEMICAL RESPONSE; GRADING SYSTEM; CIRRHOSIS; PROGNOSIS; PROGRESSION; RISK; PREDICTION; SURVIVAL;
D O I
10.1016/j.clinre.2021.101770
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Primary biliary cholangitis (PBC) is a chronic inflammatory disease of the intra-hepatic bile ducts [1] . It is characterised biologically by chronic cholestasis associated with the presence of specific autoantibodies, and histologically by lesions of nonsuppurative destructive cholangitis. If left untreated it can progress to cirrhosis, portal hypertension and liver failure. Diagnosis, staging and follow-up are largely based on non-or minimally-invasive assessment (blood tests, ultrasound, liver stiffness measurement). Histological examination of the liver and upper gastrointestinal endoscopy are sometimes necessary, but their indications remain limited. The purpose of this chapter is to provide the clinicians with what should be known about the non-invasive assessment of PBC and to provide specific recommendations for clinical practice. (c) 2021 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Fizazi, K.
    Greco, F. A.
    Pavlidis, N.
    Pentheroudakis, G.
    ANNALS OF ONCOLOGY, 2011, 22 : vi64 - vi68
  • [42] Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up
    Labianca, R.
    Nordlinger, B.
    Beretta, G. D.
    Brouquet, A.
    Cervantes, A.
    ANNALS OF ONCOLOGY, 2010, 21 : v70 - v77
  • [43] Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Pavlidis, N.
    Briasoulis, E.
    Pentheroudakis, G.
    ANNALS OF ONCOLOGY, 2010, 21 : v228 - v231
  • [44] Non-invasive Home Ventilation: Pathophysiology, Initation, Follow-Up
    Spiesshoefer, Jens
    Storre, Jan Hendrik
    Dreher, Michael
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2021, 146 (22) : 1497 - 1506
  • [45] Follow-up and management of non-invasive home mechanical ventilation
    Tintignac, A.
    Gonzalez-Bermejo, J.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2009, 65 (04) : 237 - 247
  • [46] Investigation of the potential of miRNA candidates as non-invasive biomarkers for the diagnosis and follow-up of colorectal cancer
    Karabulut, Senem
    Sen, Sena
    Soydinc, Hilal Oguz
    Dogan, Izzet
    Tastekin, Didem
    Karabulut, Mehmet
    Duman, Mustafa
    Turan, Mustafa
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 254
  • [47] Testicular non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Schmoll, H. -J.
    Jordan, K.
    Huddart, R.
    Pes, M. P. Laguna
    Horwich, A.
    Fizazi, K.
    Kataja, V.
    ANNALS OF ONCOLOGY, 2010, 21 : v147 - v154
  • [48] Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up
    Bellmunt, J.
    Orsola, A.
    Leow, J. J.
    Wiegel, T.
    De Santis, M.
    Horwich, A.
    ANNALS OF ONCOLOGY, 2014, 25 : 40 - 48
  • [49] Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up
    Bellmunt, J.
    Orsola, A.
    Maldonado, X.
    Kataja, V.
    ANNALS OF ONCOLOGY, 2010, 21 : v134 - v136
  • [50] Melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Dummer, R.
    Hauschild, A.
    Guggenheim, M.
    Jost, L.
    Pentheroudakis, G.
    ANNALS OF ONCOLOGY, 2010, 21 : v194 - v197